Apollo Hospitals has approved the re-appointment of Ms. Rama Bijapurkar as an Independent Director for a second term. The Board of Directors approved the proposal based on the recommendation of the Nomination and Remuneration Committee. The re-appointment is subject to the approval of the company's shareholders by way of a special resolution at the ensuing Annual General Meeting.

Ms. Bijapurkar's first five-year term as an Independent Director is set to expire on November 12, 2026. The new term will commence immediately following the conclusion of her current tenure and will extend for five consecutive years until November 11, 2031. The company confirmed that she is not debarred from holding the office of director by any order passed by SEBI or other authorities.

Re-appointment Details

The board meeting to finalize the re-appointment was held on May 20, 2026. The decision aligns with the provisions of Section 149 of the Companies Act, 2013, and Regulation 16 & 25 of the SEBI Listing Regulations, 2015. Ms. Bijapurkar is not related to any Directors or Key Managerial Personnel of the company.

Profile of Ms. Rama Bijapurkar

Ms. Rama Bijapurkar is a recognized thought leader on business-market strategy and India's consumer economy. She brings over four decades of experience in consulting, research, and teaching, focusing on customer centricity in business strategy and public policy. She is among India's most experienced independent board directors, having served on the boards of several blue-chip companies across financial services, IT, energy, and consumer packaged goods sectors.

She holds a BSc (Hons) degree in Physics from Delhi University and a post-graduate diploma in management from the Indian Institute of Management, Ahmedabad. Her professional background includes tenure with McKinsey & Company, MARG (now Nielsen India), and Mode Services (now TNS India), alongside running her own consulting practice.

Apollo Hospitals has outlined an ambitious expansion strategy that includes the addition of 800 more beds, with Gurugram identified as a key location for growth. The company's pipeline is targeted towards 2027, signalling a structured, multi-year approach to scaling its hospital infrastructure and service capacity.

Strong Revenue Performance

Apollo Hospitals reported 21% yearly revenue growth, driven by solid performance across its operations, as reported by CNBC TV18. The double-digit growth rate underscores the company's continued momentum in the healthcare sector.

Expansion Plans at a Glance

The following table summarises the key highlights of Apollo Hospitals' current expansion and financial developments:

₹750 Crore From Apollo Fertility Merger

Apollo Hospitals is set to receive ₹750 crore in cash arising from the merger of its Apollo Fertility business. The company has indicated that these funds will be deployed to expand its diagnostics and primary healthcare network, reflecting a strategic focus on broadening its healthcare delivery footprint beyond acute hospital care.

Strategic Focus on Healthcare Infrastructure

The combination of bed additions, geographic expansion into Gurugram, and the reinvestment of merger proceeds into diagnostics and primary healthcare highlights Apollo Hospitals' multi-pronged approach to growth. The planned capacity additions and network expansion are aligned with the company's broader 2027 growth pipeline.